Investments in progress

We are out there looking for the next big thing or at the office analyzing, verifying the facts, and drafting agreements. Sign up and we will let you know once have found something great.

Our portfolio companies

Our portfolio companies are currently developing diagnostics for early detection of cancer via blood sample, saving lives in emergency care and surgery through software innovations, developing personalised treatments of severe diseases, and much more.

Neuron cell close-up 3D rendering illustration with nervous impulses along the dendrites, the axon, the soma and nucleus. Neuronal and brain activity, nervous system, neuroscience, neurology, anatomy, medicine concepts.

Pharmnovo AB

PharmNovo is a pharmaceutical company at the clinical stage of developing a unique type of treatment for nerve pain (neuropathic pain), a condition currently lacking effective and safe treatment. The company is currently finalising its clinical phase I study and is advancing its preparations for a phase II study.

Neogap Therapeutics AB

NEOGAP Therapeutics develops a new type of personalised therapy for the treatment of cancer. The company uses proprietary machine learning algorithms and patented technology to tailor the treatment for each patient and its specific tumour cells.

Read more

Encare AB

Encare not only contributes to more cost-effective surgery but also reduces complications and saves lives through their proprietary software solution that helps hospitals implement best practice throughout the entire care chain – from diagnosis and preparation to surgery and rehabilitation.

Read more

Capitainer - Medtech-platform for self-sampling of blood

Capitainer AB

Capitainer offers a unique platform for the self-sampling of fingertip blood and plasma based on a patented microfluidic technology. The products enable easy home sampling with high precision, delivering value across the entire care chain.

Read more

Exits

Former portfolio companies that have reached new heights through acquisition or listing, and continue to thrive under new ownership. These companies continue to make a lasting impact in their respective industries.

Liv Diagnostics

Tumor cell proliferation causes 90% of all cancer deaths. Liv Diagnostics is developing new technology to measure the spreading capacity of tumor cells and provide predictive information on the risk of metastasis.

Read more

Medpro

Medpro’s business concept is to acquire and operate healthcare centres and specialist clinics at small locations in Västra Götaland County. They apply a so-called “design-in-healthcare” concept and have a clear client focus.

Read more

Raytelligence

Raytelligence has developed a unique, non-intrusive radar sensor and cloud platform for monitoring vital signs, such as respiration, heartbeat and position and movement. The company focuses on elderly care in the home.

Read more

Learning to Sleep

Learning to Sleep is a digital sleep clinic. The company offers an evidence-based treatment that uniquely combines support from a sleep coach with digital aids.

Read more